Suchergebnisse - Misti Linaberry
- Treffer 1 - 3 von 3
-
1
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr... von Bruce Strober, Diamant Thaçi, Howard Sofen, Leon Kircik, Kenneth B. Gordon, Peter Foley, Phoebe Rich, C. Paul, Jerry Bagel, Elizabeth Colston, John Throup, Sudeep Kundu, Chitra Sekaran, Misti Linaberry, Subhashis Banerjee, Kim Papp
Veröffentlicht 2022Artigo -
2
Randomized comparison of daclatasvir + asunaprevir versus telaprevir + peginterferon/ribavirin in Japanese hepatitis C virus patients von Hiromitsu Kumada, Fumitaka Suzuki, Yoshiyuki Suzuki, Joji Toyota, Yoshiyasu Karino, Kazuaki Chayama, Yoshiiku Kawakami, Shigetoshi Fujiyama, Takayoshi Ito, Yoshito Itoh, E. Tamura, Tomoko Ueki, Hiroki Ishikawa, Wenhua Hu, Fiona McPhee, Misti Linaberry, Eric Hughes
Veröffentlicht 2015Artigo -
3
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis von Andrew Blauvelt, Emma Guttman‐Yassky, Charles Lynde, Saakshi Khattri, Joel Schlessinger, Shinichi Imafuku, Yayoi Tada, Akimichi Morita, Marni Wiseman, Bartłomiej Kwiek, Martina Machkova, Peijin Zhang, Misti Linaberry, Jie Li, Sandra Zhang, Giovanni Franchin, Edgar D. Charles, Claudia H.M.C. De Oliveira, Jonathan I. Silverberg
Veröffentlicht 2024Artigo
Suchwerkzeuge:
Ähnliche Schlagworte
Medicine
Adverse effect
Dermatology
Gastroenterology
Internal medicine
Alternative medicine
Apremilast
Atopic dermatitis
Boceprevir
Clinical trial
Daclatasvir
Dermatology Life Quality Index
Hepatitis C
Hepatitis C virus
Law
MEDLINE
Pathology
Placebo
Political science
Psoriasis
Psoriasis Area and Severity Index
Psoriatic arthritis
Randomized controlled trial
Ribavirin
Telaprevir
Virology
Virus